![Samuel Levy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Samuel Levy is currently the Chief Scientific Officer at ClearNote Health, Inc. He previously held the position of Chief Scientific Officer at Genomic Health, Inc. Dr. Levy completed his undergraduate degree at the University of Leeds and obtained a doctorate degree from the University of Bristol.
| Unternehmen | Position | Beginn |
|---|---|---|
ClearNote Health, Inc.
 ClearNote Health, Inc. Pharmaceuticals: MajorHealth Technology Develops epigenetic medicines | Technik-/Wissenschafts-/F&E-Leiter | - |
| Unternehmen | Position | Ende |
|---|---|---|
| GENOMIC HEALTH, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 4 |
|---|---|
Genomic Health, Inc.
 Genomic Health, Inc. Medical/Nursing ServicesHealth Services Engages in genomic-based diagnostic tests for overtreatment and optimal treatment of early stage cancer | Health Services |
University of Leeds
 University of Leeds Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Bristol
 University of Bristol Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ClearNote Health, Inc.
ClearNote Health, Inc. Pharmaceuticals: MajorHealth Technology Develops epigenetic medicines | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
